Xtant Medical Holdings Stock Performance
| XTNT Stock | USD 0.58 0.01 1.69% |
The firm maintains a market beta of -0.8, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Xtant Medical are expected to decrease at a much lower rate. During the bear market, Xtant Medical is likely to outperform the market. At this point, Xtant Medical Holdings has a negative expected return of -0.0446%. Please make sure to check out Xtant Medical's maximum drawdown, as well as the relationship between the daily balance of power and relative strength index , to decide if Xtant Medical Holdings performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Xtant Medical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Xtant Medical is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Last Split Factor 1:12 | Dividend Date 2018-02-14 | Last Split Date 2018-02-14 |
1 | 3 Promising Penny Stocks With Over 90M Market Cap | 12/09/2025 |
2 | Will Xtant Medical Holdings Inc. stock split again soon - Quarterly Performance Summary Real-Time Chart Pattern Alerts - ulpravda.ru | 01/08/2026 |
3 | Disposition of 8084 shares by Scott Neils of Xtant Medical at 0.65 subject to Rule 16b-3 | 01/15/2026 |
4 | Xtant Medical Extends Note Maturity After Asset Divestitures - TipRanks | 01/16/2026 |
5 | Insider Trading | 02/09/2026 |
6 | Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference | 02/20/2026 |
| Begin Period Cash Flow | 5.9 M | |
| Total Cashflows From Investing Activities | -3.7 M |
Xtant Medical Relative Risk vs. Return Landscape
If you would invest 62.00 in Xtant Medical Holdings on November 22, 2025 and sell it today you would lose (3.79) from holding Xtant Medical Holdings or give up 6.11% of portfolio value over 90 days. Xtant Medical Holdings is currently does not generate positive expected returns and assumes 3.548% risk (volatility on return distribution) over the 90 days horizon. In different words, 31% of stocks are less volatile than Xtant, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Xtant Medical Target Price Odds to finish over Current Price
The tendency of Xtant Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.58 | 90 days | 0.58 | about 87.86 |
Based on a normal probability distribution, the odds of Xtant Medical to move above the current price in 90 days from now is about 87.86 (This Xtant Medical Holdings probability density function shows the probability of Xtant Stock to fall within a particular range of prices over 90 days) .
Xtant Medical Price Density |
| Price |
Predictive Modules for Xtant Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Xtant Medical Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Xtant Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Xtant Medical is not an exception. The market had few large corrections towards the Xtant Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Xtant Medical Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Xtant Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | -0.8 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | -0.05 |
Xtant Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Xtant Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Xtant Medical Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Xtant Medical generated a negative expected return over the last 90 days | |
| Xtant Medical has some characteristics of a very speculative penny stock | |
| Xtant Medical has high historical volatility and very poor performance | |
| Xtant Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 117.27 M. Net Loss for the year was (16.45 M) with profit before overhead, payroll, taxes, and interest of 82.54 M. | |
| Xtant Medical Holdings currently holds about 16.5 M in cash with (11.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Xtant Medical has a very weak financial position based on the latest SEC disclosures | |
| Roughly 58.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference |
Xtant Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Xtant Stock often depends not only on the future outlook of the current and potential Xtant Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Xtant Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 133.7 M | |
| Cash And Short Term Investments | 6.2 M |
Xtant Medical Fundamentals Growth
Xtant Stock prices reflect investors' perceptions of the future prospects and financial health of Xtant Medical, and Xtant Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Xtant Stock performance.
| Return On Equity | 0.0364 | ||||
| Return On Asset | 0.0387 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 103.92 M | ||||
| Shares Outstanding | 140 M | ||||
| Price To Earning | (0.41) X | ||||
| Price To Book | 1.62 X | ||||
| Price To Sales | 0.62 X | ||||
| Revenue | 117.27 M | ||||
| Gross Profit | 82.54 M | ||||
| EBITDA | (7.88 M) | ||||
| Net Income | (16.45 M) | ||||
| Cash And Equivalents | 16.5 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 35.14 M | ||||
| Debt To Equity | 0.60 % | ||||
| Current Ratio | 3.57 X | ||||
| Book Value Per Share | 0.36 X | ||||
| Cash Flow From Operations | (11.9 M) | ||||
| Earnings Per Share | 0.01 X | ||||
| Market Capitalization | 82.46 M | ||||
| Total Asset | 93.84 M | ||||
| Retained Earnings | (259.46 M) | ||||
| Working Capital | 38.53 M | ||||
| Current Asset | 45.04 M | ||||
| Current Liabilities | 21.47 M | ||||
About Xtant Medical Performance
Assessing Xtant Medical's fundamental ratios provides investors with valuable insights into Xtant Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Xtant Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 330.61 | 378.37 | |
| Return On Tangible Assets | (0.19) | (0.20) | |
| Return On Capital Employed | (0.19) | (0.17) | |
| Return On Assets | (0.16) | (0.17) | |
| Return On Equity | (0.44) | (0.42) |
Things to note about Xtant Medical Holdings performance evaluation
Checking the ongoing alerts about Xtant Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Xtant Medical Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Xtant Medical generated a negative expected return over the last 90 days | |
| Xtant Medical has some characteristics of a very speculative penny stock | |
| Xtant Medical has high historical volatility and very poor performance | |
| Xtant Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 117.27 M. Net Loss for the year was (16.45 M) with profit before overhead, payroll, taxes, and interest of 82.54 M. | |
| Xtant Medical Holdings currently holds about 16.5 M in cash with (11.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Xtant Medical has a very weak financial position based on the latest SEC disclosures | |
| Roughly 58.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference |
- Analyzing Xtant Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Xtant Medical's stock is overvalued or undervalued compared to its peers.
- Examining Xtant Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Xtant Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Xtant Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Xtant Medical's stock. These opinions can provide insight into Xtant Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.